TechNavio recognizes the following companies as the key players in the Global Atherectomy and Thrombectomy Market: Atherectomy Market- Covidien , Cardiovascular Systems Inc., Bayer AG, Spectranetics Corp. and Boston Scientific Corp. Thrombectomy Market- Bayer, Covidien, Straub Medical AG, Getinge AB, Boston Scientific Corp., Vascular Solutions Inc. and Spectranetics Corp.
Commenting on the report, an analyst from TechNavio™s Healthcare team said:”There has been a rapid increase in the number of new products in the Global Atherectomy and Thrombectomy Devices market in the recent years because of the significant increase in the number of reputed vendors in this market. Moreover, many of these devices have received FDA approval, which has increased accessibility to new peripheral vascular devices for patients worldwide. In addition, patent grants for many reputed vendors are increasing. For instance, Sorin Group received FDA approval for its implantable cardioverter defibrillator. Similarly, LifeStent and LifeStent XL Vascular Stent Systems, manufactured by Bard Peripheral Vascular Inc., received FDA approval in December 2010. Furthermore, Cordis Corp. announced the approval of the EXOSEAL Vascular Closure Device in May 2011. Cordis Corp. also received the FDA approval for its 2.25 mm CYPHER in 2009. In addition, Biosense Webster Inc. received FDA clearance for its CARTO 3 System in 2009. Thus, the increasing number of patent grants and FDA approvals is an emerging trend that is expected to have a positive impact on the market during the forecast period. ”
According to the report, one of the key drivers in this market is the significant increase in the prevalence of diseases such as AAAs and PADs. Moreover, the increase in the aging population, lifestyle changes and unhealthy habits, as well as the presence of genetic and co-morbid influences among patients has resulted in high incidence of acute PVD across the globe.
Further, the report states that one of the major challenges in the market is the lack of awareness about PVDs among patients. This is mainly due to the asymptomatic nature of vascular diseases, where patients do not realize their immediate symptoms.
The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are Abbott Laboratories Inc., Cordis Corp., 3M Company , Aerotel Medical Systems Ltd., American Heart Association Inc., Asian Heart Institute, Boston Scientific Corp., C.R. Bard Inc., Cook Medical Inc., ev3 Inc., Heartware International Ltd., Medtronic Inc., Nihon Kohden Corp., Smith and Nephew plc, Sorin Group USA Inc., St. Jude Medical Inc., Terumo Medical Corp., Uscom Ltd., Ventracor Ltd., and Zoll Medical Corp.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/content/global-atherectomy-and-thrombectomy-dev…
TechNavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our Engineering market research, please visit https://www.technavio.com/healthcare
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Research Report “ Global Atherectomy and Thrombectomy Market 2012-2016
